奥翔药业：甲磺酸伊马替尼片是全球首个抗肿瘤分子靶向药物用于治疗慢性粒细胞白血病急变期

互动易2025-06-10

有投资者向奥翔药业提问，公司生产的甲磺酸伊马替尼片都有哪些功效？属于创新药吗？公司回答表示，投资者您好：甲磺酸伊马替尼片是全球首个抗肿瘤分子靶向药物，用于治疗慢性粒细胞白血病（CML）急变期、加速期或α-干扰素治疗失败后的慢性期患者、不能手术切除或发生转移的恶性胃肠道间质肿瘤（GIST）患者。甲磺酸伊马替尼制剂商品名为格列卫（Gleevec）。该药品为仿制药。感谢您对公司的关注！

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2542780396?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-10 16:24","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2542780396","market":"sh","top_or_hot":-1,"title":"奥翔药业：甲磺酸伊马替尼片是全球首个抗肿瘤分子靶向药物用于治疗慢性粒细胞白血病急变期","media":"互动易","content":"<div>\n<p>有投资者向奥翔药业提问， 公司生产的甲磺酸伊马替尼片都有哪些功效？属于创新药吗？公司回答表示，投资者您好：甲磺酸伊马替尼片是全球首个抗肿瘤分子靶向药物，用于治疗慢性粒细胞白血病（CML）急变期、加速期或α-干扰素治疗失败后的慢性期患者、不能手术切除或发生转移的恶性胃肠道间质肿瘤（GIST）患者。甲磺酸伊马替尼制剂商品名为格列卫（Gleevec）。该药品为仿制药。感谢您对公司的关注！</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610163048a4a19ab6&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>奥翔药业：甲磺酸伊马替尼片是全球首个抗肿瘤分子靶向药物用于治疗慢性粒细胞白血病急变期</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n奥翔药业：甲磺酸伊马替尼片是全球首个抗肿瘤分子靶向药物用于治疗慢性粒细胞白血病急变期\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-10 16:24 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610163048a4a19ab6&s=b><strong>互动易</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>有投资者向奥翔药业提问， 公司生产的甲磺酸伊马替尼片都有哪些功效？属于创新药吗？公司回答表示，投资者您好：甲磺酸伊马替尼片是全球首个抗肿瘤分子靶向药物，用于治疗慢性粒细胞白血病（CML）急变期、加速期或α-干扰素治疗失败后的慢性期患者、不能手术切除或发生转移的恶性胃肠道间质肿瘤（GIST）患者。甲磺酸伊马替尼制剂商品名为格列卫（Gleevec）。该药品为仿制药。感谢您对公司的关注！</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610163048a4a19ab6&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610163048a4a19ab6&s=b","article_id":"2542780396","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610163048a4a19ab6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2542780396","pubTimestamp":1749543841,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"有投资者向奥翔药业提问， 公司生产的甲磺酸伊马替尼片都有哪些功效？属于创新药吗？公司回答表示，投资者您好：甲磺酸伊马替尼片是全球首个抗肿瘤分子靶向药物，用于治疗慢性粒细胞白血病（CML）急变期、加速期或α-干扰素治疗失败后的慢性期患者、不能手术切除或发生转移的恶性胃肠道间质肿瘤（GIST）患者。甲磺酸伊马替尼制剂商品名为格列卫（Gleevec）。该药品为仿制药。感谢您对公司的关注！","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603229":"奥翔药业","BK0239":"医药制造"},"translate_title":"Aoxiang Pharmaceutical: Imatinib mesylate tablets are the world's first anti-tumor molecular targeted drug for the treatment of the blast phase of chronic myeloid leukemia","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603229":1},"content_text":"有投资者向奥翔药业提问， 公司生产的甲磺酸伊马替尼片都有哪些功效？属于创新药吗？公司回答表示，投资者您好：甲磺酸伊马替尼片是全球首个抗肿瘤分子靶向药物，用于治疗慢性粒细胞白血病（CML）急变期、加速期或α-干扰素治疗失败后的慢性期患者、不能手术切除或发生转移的恶性胃肠道间质肿瘤（GIST）患者。甲磺酸伊马替尼制剂商品名为格列卫（Gleevec）。该药品为仿制药。感谢您对公司的关注！","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2542780396","isCrawlerRequest":true}